Evidence map›Paper›PMID 42567953›Full record

ReviewNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026

The neurologist of 2050: Rethinking the role in movement disorders in a technologically transformed society.

Silvia Gallo, Carlo Alberto Artusi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Silvia GalloDepartment of Clinical Pharmacology and Neurosciences, Toulouse University Hospital, ToNIC - Toulouse Neuro Imaging Centre - INSERM - UMR 1214, Toulouse, France.
Carlo Alberto ArtusiDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. caartusi@gmail.com.ORCID http://orcid.org/0000-0001-8579-3772

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionArtificial intelligence (AI), digital health technologies, and neuroengineering are rapidly transforming the diagnosis and management of movement disorders. By 2050, these innovations, together with profound demographic, cultural, and economic changes, are expected to reshape the role of neurologists far beyond current clinical practice.

methodsmovement disorder specialists may evolve from a primarily diagnostic clinician into an orchestrator of personalized neurocare, integrating multimodal digital biomarkers, AI-driven decision support systems, wearable technologies, closed-loop neuromodulation,and disease-modifying therapies. RESULTS AND DISCUSSION: We argue that future neurological care will increasingly rely on continuous home-based monitoring, predictive modeling, and individualized therapeutic strategies based on biological, clinical and 'social' information rather than purely clinical disease definitions. At the same time, population aging, healthcare sustainability, and disparities in access toadvanced technologies will require neurologists to assume broader responsibilities as multidisciplinary coordinators, integrating clinicalexpertise with data science, ethics, and health economics. Despite the growing role of AI, clinical reasoning, empathy, communication,and shared decision-making will remain irreplaceable components of neurological care. Rather than replacing neurologists, AI is likelyto increase the need for highly trained specialists capable of critically interpreting algorithmic outputs, recognizing their limitations, andcontextualizing recommendations within each patient's biological, psychological, and social framework. The neurologist of 2050 willtherefore become not only a clinician, but also a guarantor of trustworthy, equitable, and human centered precision neurology.

Indexed as

Artificial IntelligenceMovement DisordersNeurologistsNeurologyDigital HealthHumansAgingMovement DisordersPersonalized medicineTechnology

Identifiers

PMID42567953

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.